The two goals of treatment for clinically localized prostate cancer are disease control and a good quality of life. At present, the options are radical surgery, conformal or conventional external-beam radiation, and interstitial radiation. This article reviews the effectiveness of these techniques, as judged by serum prostate specific antigen monitoring, with special emphasis on magnetic resonance-guided interstitial brachytherapy.
|Original language||English (US)|
|Number of pages||9|
|State||Published - Jan 1 1999|
ASJC Scopus subject areas